tiprankstipranks
Santen Pharmaceutical Concludes Share Buyback
Company Announcements

Santen Pharmaceutical Concludes Share Buyback

Santen Pharmaceutical Co (JP:4536) has released an update.

Don't Miss our Black Friday Offers:

Santen Pharmaceutical Co., Ltd. has completed a share buyback program, repurchasing 3,066,700 common shares for a total of 4.92 billion yen within the period from June 1 to June 30, 2024. This buyback is part of a larger plan, announced by the Board of Directors on May 9, 2024, to buy back up to 21.11 million shares, representing 5.8% of the total shares outstanding, for a maximum total of 38 billion yen by November 6, 2024.

For further insights into JP:4536 stock, check out TipRanks’ Stock Analysis page.

Related Articles
TheFlyClearside Biomedical’s partner signed new collaboration agreement with Santen
TipRanks Japan Auto-Generated NewsdeskSanten Pharmaceutical Co. Reports Mixed Financial Results
TipRanks Japan Auto-Generated NewsdeskSanten Completes Strategic Share Buyback
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App